London - Kings College London

Kings College London (KCL) ECMC aims to expand its clinical and translational research trials portfolio, increase patient recruitment to trials and link with existing cancer clinical and histopathological data systems in the Network. The Centre focuses on breast, leukaemia, melanoma, and skin cancer. Areas of expertise include genetics/genomics, imaging, cell and gene-based therapy, tissue-based proteomics and immunotherapy.

Clinical Focus Area

  • Medical Oncology
  • Surgery
  • Imaging
  • Early Phase Trials

 

Scientific Focus Area

  • Metastatic Mechanisms
  • Molecular Imaging
  • Tumour Stem Cells
  • Tumour Models
  • Signal Transduction
 

Disease Focus Area

Breast Leukaemia Lung Melanoma
Oral Cavity and Lip Prostate    
 

Goals

Goals

For further information on the goals and objectives of KCL ECMC go to:

More about Goals

 

Skills

Skills

KCL ECMC principal investigators and staff have a range of skills and expertise.

More about Skills

 

Facilities

Facilities

KCL ECMC has access to a range of research facilities that are utilised in studies.

More about Facilities